X0S Stock Chart & Stats
€0.16
-€0.02(-10.32%)
At close: 4:00 PM EST
€0.16
-€0.02(-10.32%)
Day’s Range― - ―
52-Week Range€0.09 - €0.30
Previous CloseN/A
Volume0.00
Average Volume (3M)51.00
Market Cap
€47.93M
Enterprise Value€21.39M
Total Cash (Recent Filing)€10.52M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding229,421,460
10 Day Avg. Volume0
30 Day Avg. Volume51
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)3.53
Price to Sales (P/S)38.63
P/FCF Ratio-7.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)€133.48K
Bulls Say, Bears Say
Bulls Say
IP & Strategic PartnershipsOngoing patent activity plus collaborations with established research and manufacturing partners provide durable technical validation and access to external R&D and prototyping resources. These relationships shorten commercialisation pathways, strengthen entry barriers versus new entrants, and support licensing or scale partnerships over the medium term.
Conservative LeverageVery low debt reduces solvency and liquidity stress while Gelion executes scale-up, preserving optionality to pursue grants, partnerships or staged equity raises. This structural balance-sheet strength mitigates bankruptcy risk during extended development timelines and supports longer-term investment in manufacturing capacity.
Technical Scale-Up ProgressAchieving target cathode aerial capacity and successful external pouch prototypes materially de-risks manufacturing scale-up. Concrete progress on core cell materials and partner-built cells strengthens the pathway to reproducible manufacturing, enables pilot commercial builds and supports later unit-cost improvements needed for durable market competitiveness.
Bears Say
Persistent Cash BurnConsistently negative operating and free cash flows create an ongoing dependency on external funding (grants, equity or partners) to sustain operations and scale. This structural cash burn constrains strategic choices, risks dilution or slower commercial roll-out, and raises execution pressure over the next several quarters.
Very Weak Revenue And ProfitabilitySmall, volatile sales and deeply negative margins indicate the business has yet to achieve scalable unit economics. Prolonged losses and equity erosion undermine financial resilience and mean successful commercialization and material revenue growth are required to justify ongoing investment and to reverse value destruction.
Execution & Technical RisksUnresolved manufacturing yield, incomplete full-cell calendar-life validation, partner disruption and deferred Integration revenues are structural execution risks. These constraints threaten timely commercialization, prolong capital needs, and could limit adoption if technical performance or partner routes to market are not secured over the next 12–24 months.
Gelion PLC News
X0S FAQ
What was Gelion PLC’s price range in the past 12 months?
Gelion PLC lowest stock price was €0.09 and its highest was €0.30 in the past 12 months.
What is Gelion PLC’s market cap?
Gelion PLC’s market cap is €47.93M.
When is Gelion PLC’s upcoming earnings report date?
Gelion PLC’s upcoming earnings report date is Nov 11, 2026 which is in 132 days.
How were Gelion PLC’s earnings last quarter?
Gelion PLC released its earnings results on Mar 02, 2026. The company reported -€0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.02.
Is Gelion PLC overvalued?
According to Wall Street analysts Gelion PLC’s price is currently Overvalued.
Does Gelion PLC pay dividends?
Gelion PLC does not currently pay dividends.
What is Gelion PLC’s EPS estimate?
Gelion PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelion PLC have?
Gelion PLC has 229,421,460 shares outstanding.
What happened to Gelion PLC’s price movement after its last earnings report?
Gelion PLC reported an EPS of -€0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.899%.
Which hedge fund is a major shareholder of Gelion PLC?
Currently, no hedge funds are holding shares in DE:X0S
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gelion PLC Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.65%
12-Months-Change
Fundamentals
Return on Equity
-42.23%
Trailing 12-Months
Asset Growth
59.13%
Trailing 12-Months
Company Description
Gelion PLC
Gelion plc, founded in 2015 and headquartered in Eveleigh, Australia, specializes in the comprehensive process of battery systems. This includes their investigation, conceptualization, engineering, manufacturing, and distribution, serving clients both within the United Kingdom and internationally. The company's prominent offering is its Endure range of zinc-bromide batteries. These energy storage solutions are deployed across a broad spectrum of applications, such as powering industrial light towers, providing storage for renewable energy installations like solar and wind farms, supporting desalination efforts, operating mining pumps, electrifying various modes of transport including passenger vehicles, heavy-duty trucks, electric buses, and trains, and fulfilling requirements for irrigation and other agricultural tasks. Additionally, their products are utilized by commercial and industrial entities, as well as by operators of electricity grids.
Technical Analysis
Options Prices
Currently, No data available
---